Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Arterial Occlusive Diseases (Phase 1/Phase 2)
Burkitt Lymphoma (Phase 1)
Cardiomyopathy, Dilated (Phase 2)
Cerebellar Ataxia (Phase 1/Phase 2)
Cerebral Palsy (Phase 1)
Chronic Limb-Threatening Ischemia (Phase 2/Phase 3)
Diabetes Mellitus, Type 1 (Phase 1/Phase 2)
Diabetes Mellitus, Type 2 (Phase 1/Phase 2)
Erectile Dysfunction (Phase 1/Phase 2)
Fibrosis (Phase 1/Phase 2)
Heart Failure (Phase 2)
Infertility, Female (Phase 1/Phase 2)
Intellectual Disability (Phase 1/Phase 2)
Kidney Failure, Chronic (Phase 1/Phase 2)
Leukemia (Phase 3)
Multiple Myeloma (Phase 3)
Myeloproliferative Disorders (Phase 3)
Myocardial Infarction (Phase 2)
Prostatic Neoplasms (Phase 1/Phase 2)
Rectal Neoplasms (Phase 1/Phase 2)
Spinal Cord Injuries (Phase 1/Phase 2)
Traumatology (Phase 1)
Ulcer (Phase 1/Phase 2)
Vasculitis (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue